Fatty acid-bearing albumin induces VCAM-1 expression through c-Src kinase-AP-1/NF-kB pathways: effect of L-carnitine

Kidney Blood Press Res. 2010;33(1):72-84. doi: 10.1159/000289576. Epub 2010 Mar 2.

Abstract

Background: Fatty acid-bearing albumin [FA(+) albumin] exerts more deleterious effects in tubular cells than albumin alone. We investigated the effect of FA(+) albumin on the vascular cell adhesion molecule-1 (VCAM-1) expression and elucidated the underlying signaling pathways. We further examined the effect of L-carnitine, since it was known to modulate intracellular fatty acid concentration.

Methods: Activation of AP-1 and NF-kappaB was assessed by electrophoretic mobility shift assay. Phosphorylation of protein kinase was examined by Western blot analysis. VCAM-1 mRNA and protein expression were measured by Northern blot analysis and cell ELISA.

Results: FA(+) albumin induced VCAM-1 expression via activation of AP-1 and NF-kappaB, which was mediated through activation of c-Src kinase, followed by MAP kinases (p38, ERK 1/2, JNK-1) and IkappaB kinase and IkappaB-alpha, respectively. Inhibitors of protein kinase C and tyrosine kinase, anti-oxidants and intracellular calcium chelator suppressed the FA(+) albumin-induced activation of c-Src kinase. L-Carnitine suppressed the FA(+) albumin-induced VCAM-1 expression via inhibition of c-Src kinase.

Conclusions: VCAM-1 expression with activation of c-Src kinase-AP-1/NFkappaB pathways might be one of the possible mechanisms that linked FA(+) albumin to tubulointerstitial injury. L-Carnitine might be beneficial in attenuating FA(+) albumin-induced tubular injury.

MeSH terms

  • Albumins / metabolism
  • Albumins / pharmacology
  • CSK Tyrosine-Protein Kinase
  • Carnitine / metabolism
  • Carnitine / pharmacology*
  • Cell Line
  • Fatty Acids / metabolism
  • Fatty Acids / pharmacology
  • Gene Expression / drug effects
  • Gene Expression / physiology
  • Humans
  • I-kappa B Proteins / metabolism
  • Kidney Diseases / drug therapy
  • Kidney Diseases / metabolism
  • Kidney Diseases / physiopathology*
  • Kidney Tubules, Proximal / cytology
  • Kidney Tubules, Proximal / physiology*
  • Lipid Metabolism / drug effects
  • Lipid Metabolism / physiology
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / metabolism
  • Protein-Tyrosine Kinases / metabolism*
  • RNA, Messenger / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Transcription Factor AP-1 / metabolism
  • Vascular Cell Adhesion Molecule-1 / genetics*
  • Vitamin B Complex / metabolism
  • Vitamin B Complex / pharmacology
  • src-Family Kinases

Substances

  • Albumins
  • Fatty Acids
  • I-kappa B Proteins
  • NF-kappa B
  • NFKBIA protein, human
  • RNA, Messenger
  • Transcription Factor AP-1
  • Vascular Cell Adhesion Molecule-1
  • Vitamin B Complex
  • NF-KappaB Inhibitor alpha
  • Protein-Tyrosine Kinases
  • CSK Tyrosine-Protein Kinase
  • src-Family Kinases
  • CSK protein, human
  • Carnitine